Literature DB >> 10425337

High-molecular weight HPMA copolymer-adriamycin conjugates.

M Dvorák1, P Kopecková, J Kopecek.   

Abstract

High-molecular weight (branched) water-soluble N-(2-hydroxypropyl)methacrylamide (HPMA) copolymers containing lysosomally degradable oligopeptide crosslinks were synthesized by radical copolymerization of HPMA and newly designed crosslinking agents, N(2), N(5)-bis(N-methacryloylglycylphenylalanylleucylglycyl)ornithine s with different modification of the carboxy group. The length of the primary chain was controlled by the addition of a chain transfer agent, 3-mercaptopropionic acid. A polymerizable derivative of the anticancer drug adriamycin (ADR), N-methacryloylglycylphenylalanylleucylglycyl adriamycin, was added to some polymerization mixtures. This resulted in high-molecular weight, branched, water-soluble HPMA copolymers containing oligopeptide sequences in the crosslinks as well as in side-chains terminated in ADR. The degradability of the crosslinks as well as the release of ADR by lysosomal enzymes isolated from rat liver were investigated.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10425337     DOI: 10.1016/s0168-3659(99)00087-5

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  19 in total

1.  HPMA-PLGA Based Nanoparticles for Effective In Vitro Delivery of Rifampicin.

Authors:  Sarita Rani; Avinash Gothwal; Pawan K Pandey; Devendra S Chauhan; Praveen K Pachouri; Umesh D Gupta; Umesh Gupta
Journal:  Pharm Res       Date:  2018-12-03       Impact factor: 4.200

2.  Selective inhibitory effect of HPMA copolymer-cyclopamine conjugate on prostate cancer stem cells.

Authors:  Yan Zhou; Jiyuan Yang; Jindřich Kopeček
Journal:  Biomaterials       Date:  2011-12-03       Impact factor: 12.479

3.  Biological activity of anti-CD20 multivalent HPMA copolymer-Fab' conjugates.

Authors:  Russell N Johnson; Pavla Kopečková; Jindřich Kopeček
Journal:  Biomacromolecules       Date:  2012-02-21       Impact factor: 6.988

4.  Influence of the structure of drug moieties on the in vitro efficacy of HPMA copolymer-geldanamycin derivative conjugates.

Authors:  Yuji Kasuya; Zheng-Rong Lu; Pavla Kopecková; S Esmail Tabibi; Jindrich Kopecek
Journal:  Pharm Res       Date:  2002-02       Impact factor: 4.200

5.  The Light at the End of the Tunnel-Second Generation HPMA Conjugates for Cancer Treatment.

Authors:  Jiyuan Yang; Jindřich Kopeček
Journal:  Curr Opin Colloid Interface Sci       Date:  2017-07-28       Impact factor: 6.448

Review 6.  Design of smart HPMA copolymer-based nanomedicines.

Authors:  Jiyuan Yang; Jindřich Kopeček
Journal:  J Control Release       Date:  2015-10-03       Impact factor: 9.776

7.  Synergistic antitumor activity of camptothecin-doxorubicin combinations and their conjugates with hyaluronic acid.

Authors:  Kathryn M Camacho; Sunny Kumar; Stefano Menegatti; Douglas R Vogus; Aaron C Anselmo; Samir Mitragotri
Journal:  J Control Release       Date:  2015-04-25       Impact factor: 9.776

8.  Combination therapy of prostate cancer with HPMA copolymer conjugates containing PI3K/mTOR inhibitor and docetaxel.

Authors:  Yan Zhou; Jiyuan Yang; Rui Zhang; Jindřich Kopeček
Journal:  Eur J Pharm Biopharm       Date:  2014-12-03       Impact factor: 5.571

Review 9.  Beyond oncology--application of HPMA copolymers in non-cancerous diseases.

Authors:  Xin-Ming Liu; Scott C Miller; Dong Wang
Journal:  Adv Drug Deliv Rev       Date:  2009-11-10       Impact factor: 15.470

Review 10.  Biological rationale for the design of polymeric anti-cancer nanomedicines.

Authors:  Yan Zhou; Jindřich Kopeček
Journal:  J Drug Target       Date:  2012-09-26       Impact factor: 5.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.